Clinical outcomes are complex and often multi-systemic. Early identification and standardization are critical to improving prognosis. Diagnosis of the disease requires a combination of clinical outcomes, imaging checks, laboratory checks and pathological evaluations.
The platform can help align a team of authoritative experts at home and abroad to provide accurate diagnosis and treatment. Treatment and management of the treatment of the Silver-Russell dwarf requires individualized management, typically including drug therapy, rehabilitation, regular follow-up, and other multidimensional management. In recent years, with the development of therapeutic, immune-regulatory therapy and precision medicine, many previously difficult to treat genetic metabolic disorders have been significantly improved.
Treatment requires close monitoring of efficacy and adverse reactions and timely adjustment according to changes in the disease. Multidisciplinary collaboration (MDT) is particularly important for the integrated management of the Silver-Russell syndrome. 2.
Visiting China: arranging face-to-face treatment with authoritative experts, developing individualized treatment plans; 3. Full-service: providing one-stop services such as medical translation, medical care, accommodation arrangements; 4. Long-term follow-up: establishing a chronic disease management archive, continuous monitoring of disease changes and treatment effects.